ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,000 | -20.0% | 400 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | +150.0% | 400 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q2 2015 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2015 | $3,000 | +50.0% | 400 | 0.0% | 0.00% | – |
| Q4 2014 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q3 2014 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2014 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q1 2014 | $3,000 | – | 400 | +515.4% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 65 | -99.2% | 0.00% | -100.0% |
| Q3 2013 | $144,000 | +4.3% | 7,891 | -0.5% | 0.01% | -14.3% |
| Q2 2013 | $138,000 | – | 7,932 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
| Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
| Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
| Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
| Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
| Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
| Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
| 1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
| HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |